Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire

Dateline City: 

WHITEHOUSE STATION, N.J.

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
today announced the appointment of Roger M. Perlmutter, M.D., Ph.D., as
executive vice president and president of Merck Research Laboratories
(MRL), effective April 15. Dr. Perlmutter will succeed Peter S. Kim,
Ph.D., who has served in the role since 2003. To ensure a seamless
transition, Dr. Perlmutter and Dr. Kim will work closely together for an
initial period, after which Dr.
Language: 

English

Contact HTML: 

MerckMedia Contacts:Steven Cragle, 908-423-3461orInvestor Contacts:Alex Kelly, 908-423-5185

Ticker Slug: 

Ticker: MRK Exchange: NYSE

read more

Source: Merck.com - Research and Development News - March 7, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Research and Development News Corporate News Latest News Source Type: news